The lack of P/E or EV/EBITDA multiples confirms that the market views the equity as a distressed asset rather than a functioning business. This valuation level warrants caution, as it implies a growth trajectory that the company's historical financial performance and current manufacturing utilization rates fail to support.

The extreme operating margin of -1053% indicates that SG&A and R&D expenses are vastly disproportionate to current output, suggesting a zombie cost structure. Investors should monitor whether the pivot to industrial applications can improve throughput, though current figures suggest margins remain deeply entrenched in negative territory.

The consistent decay in returns on invested capital suggests that the firm's specialized ceramic manufacturing assets are not generating sufficient economic value to justify their maintenance. This trend appears structural, as the company has failed to convert its intellectual property into a self-sustaining return profile.

The high days inventory outstanding, which reached 255 days in 2026Q1, suggests that specialized ceramic components are sitting idle, potentially indicating obsolescence risks. This inefficiency in working capital management appears to be a primary driver of the company's persistent cash burn and inability to optimize its operational cycle.

The rising leverage, combined with the lack of positive EBITDA, suggests that debt service is becoming increasingly difficult, potentially limiting the company's ability to secure non-dilutive financing. Investors should monitor the interest coverage ratio, which remains deeply negative, signaling a high risk of future refinancing difficulties.